Chemoinformaics analysis of I-22,23-Dihydrostigmasterol
| Molecular Weight | 414.718 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 21 |
| Exact Molecular Weight | 414.386 | nRing | 5 |
| Solubility: LogS | -6.792 | nHRing | 0 |
| Solubility: LogP | 7.267 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 82.5716 |
| nHD | 1 | BPOL | 50.1604 |
| QED | 0.472 |
| Synth | 5.14 |
| Natural Product Likeliness | 2.866 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.181 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.889 |
| MDCK | 0.0000142 |
| BBB | 0.92 |
| PPB | 0.995684 |
| VDSS | 1.713 |
| FU | 0.0139379 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.493 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.958 |
| CYP2c9-inh | 0.084 |
| CYP2c9-sub | 0.382 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.633 |
| CYP3a4-inh | 0.177 |
| CYP3a4-sub | 0.678 |
| CL | 19.34 |
| T12 | 0.012 |
| hERG | 0.432 |
| Ames | 0.04 |
| ROA | 0.06 |
| SkinSen | 0.849 |
| Carcinogencity | 0.016 |
| EI | 0.01 |
| Respiratory | 0.637 |
| NR-Aromatase | 0.022 |
| Antiviral | No |
| Prediction | 0.642788 |